GTBP·36254L308·US·equity·Healthcare - Biotechnology-13D/G
GTBP (GT BIOPHARMA INC) is held by 17 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($120,170), CITADEL ADVISORS LLC ($27,002), UBS Group AG ($18,756). Net institutional sentiment: Mixed.
See how GTBP's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer